跳至主要内容
临床试验/NCT00570141
NCT00570141已完成4 期

Case Study Documentation of Subjects With Either Diabetic Foot Ulcers or Venous Stasis Ulcers Being Treated With OASIS

Healthpoint6 个研究点 分布在 1 个国家目标入组 13 人开始时间: 2007年10月最近更新:
适应症
干预措施

试验速览

阶段
4 期
状态
已完成
发起方
Healthpoint
入组人数
13
试验地点
6
主要终点
Percent Wounds Closed

研究概览

简要总结

OASIS Wound Matrix (Oasis) will be applied to wounds, with sequential biopsy of healing wounds to explore the mechanism of action.

详细描述

Wound types will be Diabetic Foot Ulcers (DFU) and Venous Stasis Ulcers (VSU).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diabetic foot ulcer (DFU) or venous stasis ulcer (VSU) of the leg, with certain restrictions on size, duration and underlying health

排除标准

  • Contraindications or hypersensitivity to the use of the study medications or their components

研究组 & 干预措施

OASIS Wound Matrix (Oasis)

Active Comparator

This is a single arm study with only the test article Oasis used on all subjects

干预措施: OASIS Wound Matrix (Device)

结局指标

主要结局

Percent Wounds Closed

时间窗: baseline and 12 weeks

Wound healing was assessed weekly, spaced 7 +/- 1 day apart, up to 12 weeks or until the wound healed, whichever occurred first. The outcome value was based on the percent of wounds which were closed at the end of the study (at 12 weeks). The percent wounds closed were calculated for each wound type: Diabetic Foot Ulcers (DFU) and Venous Stasis Ulcers (VSU).

Decrease in Wound Area From Baseline After 12 Weeks of Treatment or Until Wound Closure, Whichever Occurred First.

时间窗: Baseline and weekly up to 12 weeks

Wound measurements were made weekly, spaced 7 +/- 1 day apart, up to 12 weeks or until the wound healed, whichever occurred first. The final measurement taken was subtracted from the baseline to assess the decrease in wound area after treatment. Final calculation is mean baseline measurement minus final measurement at 12 weeks (or when wound healed, whichever occurred first)

次要结局

未报告次要终点

研究者

发起方
Healthpoint
申办方类型
Industry

研究点 (6)

Loading locations...

相似试验